Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome (GLUT1 DS)

NCT02036853 is registered in ClinicalTrials.gov with Adrian Lacy as lead sponsor.

NCT NCT02036853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02036853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome (GLUT1 DS)
Lead sponsor
Adrian Lacy
Phase
Phase 2
Overall status
Completed
Start date
February 20, 2014
Completion date
June 30, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose transporter type-1 deficiency syndrome (glut1 ds)